In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
A superbug that does not respond to the very last ditch antibiotics and that has been circulating in Asia and Europe arrives ...
The nonprofit said its new tool, using data from urine tests, has already picked up a spike of carfentanil, a potent and ...
The hazards associated with microplastic pollution are becoming increasingly recognized. However, one study suggests that researchers have misjudged the impacts of nanoplastics — the insidiously ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback